Publications by authors named "Ota Fuchs"

Claim this Profile
T
Targeting cereblon in hematologic malignancies.
Ota Fuchs

Blood Rev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Studies of PROTACs in Hematological Malignancies.
Ota Fuchs, Radka Bokorova

Cardiovasc Hematol Disord Drug Targets· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes.
Miroslav Pribyl, Sona Hubackova, Alena Moudra, Marketa Vancurova, Helena Polackova, Ota Fuchs

Mol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs.
Ota Fuchs

Cardiovasc Hematol Disord Drug Targets· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant and Mutations.
Barbora Brodská, Petra Otevřelová, Cyril Šálek, Ota Fuchs, Zdenka Gašová

Int J Mol Sci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin.
Kateřina Kuželová, Barbora Brodská, Johannes Schetelig, Christoph Röllig, Zdeněk Ráčil, Ota Fuchs

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide treatment in lower risk myelodysplastic syndromes-The experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients).
Anna Jonasova, Radana Neuwirtova, Helena Polackova, Magda Siskova, Tomas Stopka, Ota Fuchs

Leuk Res· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of serum for identification of potential biomarkers predicting response of patients with refractory multiple myeloma to bortezomib‑based therapy.
Ota Fuchs

Pol Arch Intern Med· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.
Kateřina Kuželová, Barbora Brodská, Ota Fuchs, Marie Dobrovolná, Petr Soukup

PLoS One· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide.
Anna Jonasova, Radka Bokorova, Jaroslav Polak, Martin Vostry, Arnost Kostecka, Ota Fuchs

Eur J Haematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CBFB-MYH11 hypomethylation signature and PBX3 differential methylation revealed by targeted bisulfite sequencing in patients with acute myeloid leukemia.
Hana Hájková, Markus Hsi-Yang Fritz, Cedrik Haškovec, Jiří Schwarz, Cyril Šálek, Ota Fuchs

J Hematol Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of NF-kappaB signaling pathway, other signaling pathways and epigenetics in therapy of multiple myeloma.
Ota Fuchs

Cardiovasc Hematol Disord Drug Targets· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia.
Radana Neuwirtova, Ota Fuchs, Monika Holicka, Martin Vostry, Arnost Kostecka

Ann Hematol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Important genes in the pathogenesis of 5q- syndrome and their connection with ribosomal stress and the innate immune system pathway.
Ota Fuchs

Leuk Res Treatment· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation.
Hana Hájková, Jana Marková, Cedrik Haškovec, Iveta Sárová, Ota Fuchs

Leuk Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unusually long survival of a 67-year-old patient with near-tetraploid acute myeloid leukemia m0 without erythroblastic and megakaryocytic dysplasia.
Petr Lemež, Hana Klamová, Zuzana Zemanová, Iuri Marinov, Ota Fuchs

Acta Haematol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcription factor NF-κB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.
Ota Fuchs

Curr Mol Pharmacol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nature of frequent deletions in CEBPA.
Ota Fuchs, Arnost Kostecka, Dana Provaznikova, Blazena Krasna, Jana Brezinova

Blood Cells Mol Dis· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A partial nontandem duplication of the MLL gene in four patients with acute myeloid leukemia.
Iveta Sárová, Jana Brezinová, Zuzana Zemanová, Libuse Lizcová, Adéla Berková, Ota Fuchs

Cancer Genet Cytogenet· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative and proapoptotic effects of proteasome inhibitors and their combination with histone deacetylase inhibitors on leukemia cells.
Ota Fuchs, Dana Provaznikova, Iuri Marinov, Katerina Kuzelova, Ivan Spicka

Cardiovasc Hematol Disord Drug Targets· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CEBPA polymorphisms and mutations in patients with acute myeloid leukemia, myelodysplastic syndrome, multiple myeloma and non-Hodgkin's lymphoma.
Ota Fuchs, Dana Provaznikova, Marcela Kocova, Arnost Kostecka, Pavla Cvekova

Blood Cells Mol Dis· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-alpha suppresses proliferation of chronic myelogenous leukemia cells K562 by extending cell cycle S-phase without inducing apoptosis.
Dana Grebenová, Katerina Kuzelová, Ota Fuchs, Petr Halada, Vladimír Havlícek

Blood Cells Mol Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Smad5 in human hematopoietic progenitors blocks erythroid differentiation induced by BMP4.
Ota Fuchs, Olga Simakova, Pavel Klener, Jana Cmejlova, Jan Zivny

Blood Cells Mol Dis· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Native electrophoretic separation and femtomolar detection of 65Zn-containing proteins by storage phosphorimaging.
Daniel Vyoral, Marek Babusiak, Ota Fuchs, Jirí Petrák

J Biochem Biophys Methods· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrial and endoplasmic reticulum stress-induced apoptotic pathways are activated by 5-aminolevulinic acid-based photodynamic therapy in HL60 leukemia cells.
Dana Grebenová, Katerina Kuzelová, Karel Smetana, Michaela Pluskalová, Hana Cajthamlová, Ota Fuchs

J Photochem Photobiol B· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis